Literature DB >> 23360804

Mindin is a critical mediator of ischemic brain injury in an experimental stroke model.

Lang Wang1, Yanyun Lu, Xin Zhang, Yan Zhang, Dingsheng Jiang, Xiaomin Dong, Shan Deng, Li Yang, Yu Guan, Lihua Zhu, Yan Zhou, Xiaodong Zhang, Hongliang Li.   

Abstract

BACKGROUND: Stroke is the second leading cause of death among adults worldwide. Mindin is an ECM protein that plays important roles in regulating inflammation, angiogenesis and neuronal outgrowth. The role of mindin in the context of brain ischemia has not been examined. METHODS AND
RESULTS: Transient occlusion of the middle cerebral artery was performed on mindin knockout (KO) mice, mice that carried a neuron-specific constitutively active mindin transgene (TG) and the appropriate controls. The outcome of the ischemia was evaluated by examination of the infarct and edema volumes and by neurological score assessments. The brains were collected 24 h or 3 days following the induced stroke. Compared with the control mice, the mindin KO mice exhibited lower infarct volumes and better outcomes in the neurological tests. Mindin-deficient mice exhibited low expression levels of stroke-induced inflammatory mediators, an attenuated recruitment of inflammatory cells, and inhibited activation of NF-κB. The neuronal apoptosis levels were also lower in the brains of the mindin KO mice than in those of the control mice. The mice that expressed a neuron-specific, constitutively active mindin transgene exhibited effects following the cerebral ischemic injury that were the opposite of those that were observed in the mindin KO mice. Moreover, Akt signaling activation was elevated in the ischemic brains of mindin KO mice.
CONCLUSIONS: Mindin KO mice exhibited minor infarctions, an attenuated inflammatory response and low levels of neuronal apoptosis following an ischemic insult. These data demonstrate that mindin is a critical mediator of ischemic brain injury in an experimental stroke model. Akt signaling most likely mediates the biological function of mindin in this model of cerebral ischemia.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2,3,5-triphenyl-2H-tetrazolium chloride; Akt; Apoptosis; CBF; ECM; GSK3; ICAM-1; IL; Inflammation; Interleukin; Ischemia; MCA; MCP-1; MMP; Mindin; NF-κB; OCT; PBS; PCR; PDGF; Stroke; TLRs; TNF; TSRs; TTC; VCAM-1; cerebral blood flow; eNOS; endothelial nitric oxide synthase; extracellular matrix; glycogen synthase kinase 3; intercellular adhesion molecule-1; mTOR; mammalian target of rapamycin; matrix metalloproteinase; middle cerebral artery; monocyte chemoattractant protein-1; nuclear factor kappa B; ornithine carbamyl transferase; phosphate buffer solution; platelet-derived growth factor; polymerase chain reaction; protein kinase B; tMCAO; tPA; thrombospondin type 1 repeats; tissue plasminogen activator; toll-like receptors; transient middle cerebral artery occlusion; tumor necrosis factor; vascular cell adhesion molecule-1

Mesh:

Substances:

Year:  2013        PMID: 23360804     DOI: 10.1016/j.expneurol.2013.01.022

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Intrinsic disorder in spondins and some of their interacting partners.

Authors:  Oluwole Alowolodu; Gbemisola Johnson; Lamis Alashwal; Iqbal Addou; Irina V Zhdanova; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2016-12-15

Review 2.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

3.  Neuroprotective Effects of (-)-Epigallocatechin-3-Gallate Against Focal Cerebral Ischemia/Reperfusion Injury in Rats Through Attenuation of Inflammation.

Authors:  FengJin Zhang; Na Li; LinLan Jiang; LongHao Chen; MuTu Huang
Journal:  Neurochem Res       Date:  2015-07-22       Impact factor: 3.996

4.  Mindin deficiency alleviates renal fibrosis through inhibiting NF-κB and TGF-β/Smad pathways.

Authors:  Kang Yang; Wei Li; Tao Bai; Yusha Xiao; Weimin Yu; Pengcheng Luo; Fan Cheng
Journal:  J Cell Mol Med       Date:  2020-04-06       Impact factor: 5.310

5.  CD73 alleviates GSDMD-mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signaling.

Authors:  Shun Xu; Jin Wang; Junjie Zhong; Minghao Shao; Jianyuan Jiang; Jian Song; Wei Zhu; Fan Zhang; Haocheng Xu; Guangyu Xu; Yuxuan Zhang; Xiaosheng Ma; Feizhou Lyu
Journal:  Clin Transl Med       Date:  2021-01

6.  Oncostatin M Confers Neuroprotection against Ischemic Stroke.

Authors:  Sen Guo; Zuo-Zhi Li; Jun Gong; Mei Xiang; Peng Zhang; Guang-Nian Zhao; Mingchang Li; Ankang Zheng; Xueyong Zhu; Hao Lei; Tanaka Minoru; Hongliang Li
Journal:  J Neurosci       Date:  2015-08-26       Impact factor: 6.167

7.  TRAF1 is a critical regulator of cerebral ischaemia-reperfusion injury and neuronal death.

Authors:  Yan-Yun Lu; Zuo-Zhi Li; Ding-Sheng Jiang; Lang Wang; Yan Zhang; Ke Chen; Xiao-Fei Zhang; Yi Liu; Guo-Chang Fan; Yingjie Chen; Qinglin Yang; Yan Zhou; Xiao-Dong Zhang; De-Pei Liu; Hongliang Li
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  IRF4 is a novel mediator for neuronal survival in ischaemic stroke.

Authors:  S Guo; Z-Z Li; D-S Jiang; Y Y Lu; Y Liu; L Gao; S-M Zhang; H Lei; L-H Zhu; X-D Zhang; D-P Liu; H Li
Journal:  Cell Death Differ       Date:  2014-02-07       Impact factor: 15.828

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.